Table 4.
Cephalometric Changes of OSAHS and Control Groups Pretreatment and Posttreatment (Positive Values Signify Increase; Negative Values Signify Decrease)
| Variable |
Control Group, Mean ± SD |
OSAHS Group, Mean ± SD |
P Value*, P < .05 |
| NSAr | 0.348 ± 1.668 | −0.739 ± 2.281 | .072 |
| SArGo | −0.609 ± 2.624 | 4.012 ± 2.393 | .035* |
| ArGoMe | 0.044 ± 2.619 | 1 ± 2.486 | .211 |
| SUM | −0.22 ± 1.596 | 2.27 ± 1.825 | .025* |
| NGoAr | −0.044 ± 1.988 | −1.044 ± 1.965 | .702 |
| NGoMe | −0.174 ± 1.696 | 0.957 ± 1.96 | .019* |
| SNGoMe | −1 ± 1.537 | 2.85 ± 1.613 | .006* |
| NSG | −0.221 ± 1.421 | 0.392 ± 1.276 | .387 |
| ANS-Xi-Pm | 0.522 ± 1.697 | 1.171 ± 1.714 | .436 |
| NBa-PtG | 0.478 ± 1.236 | 0.313 ± 1.663 | .704 |
| DC-Xi-Pm | 1.144 ± 3.286 | 0.226 ± 2.881 | .32 |
| SAr:ArGo | −3.044 ± 5.085 | −2.391 ± 4.429 | .654 |
| GoMe:NS | 2.565 ± 3.087 | 1.608 ± 2.692 | .269 |
| SGo:NMe | 1.019 ± 1.49 | 0.031 ± 2.027 | .908 |
*
P < .05.